Charlotte Dyring
Gründer bei ExpreS2ion Biotechnologies ApS
Aktive Positionen von Charlotte Dyring
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Gründer | 01.01.2009 | - |
Geschäftsführer | - | - | |
Vorstandsvorsitzender | 26.04.2011 | - |
Karriereverlauf von Charlotte Dyring
Ehemalige bekannte Positionen von Charlotte Dyring
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EXPRES2ION BIOTECH HOLDING AB | Geschäftsführer | 01.01.2010 | 01.12.2020 |
Gründer | 01.01.2010 | 01.12.2020 | |
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Corporate Officer/Principal | 01.01.1995 | - |
Kabi Pharmacia | Corporate Officer/Principal | - | - |
Ausbildung von Charlotte Dyring
Technical University of Denmark | Doctorate Degree |
The Danish Academy of Technical Sciences | Undergraduate Degree |
Statistik
International
Dänemark | 7 |
Operativ
Chief Operating Officer | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EXPRES2ION BIOTECH HOLDING AB | Health Technology |
Private Unternehmen | 3 |
---|---|
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Health Technology |
Kabi Pharmacia | |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
- Börse
- Insiders
- Charlotte Dyring
- Erfahrung